Clinical implications of genomic evaluations for prostate cancer risk stratification, screening, and treatment: a narrative review
New classification systems based on molecular features have been introduced to improve precision medicine for prostate cancer (PCa). This review covers the increasing risk of PCa and the differences in response to targeted therapy that are related to specific gene variations. We believe that genomic...
| Hlavní autoři: | , , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
Elsevier
2020-09-01
|
| Edice: | Prostate International |
| Témata: | |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S228788822030057X |